In summary, our findings demonstrate that pharmacological inhibition of soluble epoxide hydrolase (sEH) with TPPU effectively attenuates alveolar bone loss in an estrogen-deficient model of experimental periodontitis. The gene discussed is EPHX2; the disease is periodontitis.